MODIFICATION TO ALKP— 510(k) K023807

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K023807 for MODIFICATION TO ALKP, Substantially Equivalent on 2002-12-26. Applicant: Abbott Laboratories.

Clearance details

Applicant
Abbott Laboratories
Product code
Code CJE
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Irving, TX, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.